Download FREE Report Sample
Download Free sampleHuman insulin is the name which describes synthetic insulin which is laboratory grown to mimic the insulin in humans.
Human Insulin Market contains market size and forecasts of Human Insulin in global, including the following market information:
Global Human Insulin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Human Insulin Market Sales, 2017-2022, 2023-2028, (K Doses)
Global top five Human Insulin companies in 2021 (%)
The global Human Insulin market was valued at 57460 million in 2021 and is projected to reach US$ 104760 million by 2028, at a CAGR of 9.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Insulin Analogs and Biosimilars Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Insulin include B. Braun, Becton, Dickinson, Biocon, Biodel, ELI Lilly, Julphar, NOVO Nordisk, Sanofi and Wockhardt and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Insulin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Insulin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Human Insulin Market Segment Percentages, by Type, 2021 (%)
Insulin Analogs and Biosimilars
Human Insulin Biologics
Global Human Insulin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Human Insulin Market Segment Percentages, by Application, 2021 (%)
Short Acting
Intermediate Acting
Long Acting
Pre-Mix Insulin
Global Human Insulin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Human Insulin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Insulin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Human Insulin revenues share in global market, 2021 (%)
Key companies Human Insulin sales in global market, 2017-2022 (Estimated), (K Doses)
Key companies Human Insulin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
B. Braun
Becton, Dickinson
Biocon
Biodel
ELI Lilly
Julphar
NOVO Nordisk
Sanofi
Wockhardt
Ypsomed
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
